Health claims and disclaimers: Extended boundaries and research opportunities in consumer interpretation

In Pearson v. Shalala the court restricts FDA authority br allowing sellers of dietary supplements to make health claims based on less than "significa nt scientific agreement" when these claims are accompanied by a disclaimer. The authors raise issues regarding the lack of standards for substantiatio n and the effectiveness of disclaimers in light of the untested nature of s ome supplements and the vulnerabilities of some supplement consumers.